Derek Bertocci Email Address

Guardant360 is the only biopsy-free tumor sequencing test that tracks tumor genomics in real-time.

CFO with more than 30 years of experience in a broad range of corporate environments. •Significant experience guiding major transactions including IPO, M&A, and corporate financing. •Successfully built and managed accounting, FP&A, tax and IT teams to handle rapid growth and change. •Particular skill employing FP&A function to identify challenges and opportunities (operational and strategic) to help companies and managers achieve growth and profit opportunities. Extensive experience guiding companies to achieve and manage rapid revenue growth •Guardant Health - 85% revenue CAGR(2016 to 2020) •Accuray - 94% revenue growth(FY2011 to FY2012) •BioForm Medical - 75% revenue CAGR(FY2006 to FY2008) •Laserscope - 37% revenue growth(2004 to 2005) •VISX - 103% revenue CAGR(1995 to 1999) Proven track record of increasing operational efficiency and profitability •Accuray - 8% pre-tax profit (FY2011 Q2) vs. 0%pre-tax breakeven (FY2009) •VISX - 52% pre-tax profit (1999) vs. (88%)pre-tax loss (1995) Guided completion of numerous successful corporate transactions (IPO, M&A, corporate financing) •Guardant Health - Convertible debt fund raising $1 Billion (November 2020) •Guardant Health - Equity fund raising $350M and $362M (May 2019 and June 2020, respectively) •Guardant Health - IPO successful, raised $273M (October 2018) •Achaogen - Debt financing $25M (August 2015); ATM equity finance program (Sept 2015) •Achaogen - IPO successful, raised $83M (March 2014) •Accuray - Successful convertible debt financing: $100M (Aug. 2011) and $115M (Feb. 2013) •Accuray - Acquired TomoTherapy, doubling company size and revenue (FY’11 to FY’12) •BioForm Medical - IPO successful, raised $92M (November 2007) •BioForm Medical - Private financing successful, raised $12M from VC investors (March 2007) •Laserscope - Sold company for $700M to AMS (50% premium over market - June 2006) •VISX - Sold company for $1.3B to AMO (50% premium over market - May 2005) Investor relations expertise Solid track record managing corporate financial compliance •Experience building and restructuring accounting teams Experienced manager of international finances & global taxes Managed IT function (new ERP systems in 5 companies)